Protein Arginine Methyltransferase 5 Suppresses the Transcription of the RB Family of Tumor Suppressors in Leukemia and Lymphoma Cells
- 1 October 2008
- journal article
- research article
- Published by Taylor & Francis in Molecular and Cellular Biology
- Vol. 28 (20), 6262-6277
- https://doi.org/10.1128/mcb.00923-08
Abstract
The proper epigenetic modification of chromatin by protein arginine methyltransferases (PRMTs) is crucial for normal cell growth and health. The human SWI/SNF-associated PRMT5 is involved in the transcriptional repression of target genes by directly methylating H3R8 and H4R3. To further understand the impact of PRMT5-mediated histone methylation on cancer, we analyzed its expression in normal and transformed human B lymphocytes. Our findings reveal that PRMT5 protein levels are enhanced in various human lymphoid cancer cells, including transformed chronic lymphocytic leukemia (B-CLL) cell lines. PRMT5 overexpression is caused by the altered expression of the PRMT5-specific microRNAs 19a, 25, 32, 92, 92b, and 96 and results in the increased global symmetric methylation of H3R8 and H4R3. An evaluation of both epigenetic marks at PRMT5 target genes such as RB1 (p105), RBL1 (p107), and RBL2 (p130) showed that promoters H3R8 and H4R3 are hypermethylated, which in turn triggers pocket protein transcriptional repression. Furthermore, reducing PRMT5 expression in WaC3CD5 B-CLL cells abolishes H3R8 and H4R3 hypermethylation, restores RBL2 expression, and inhibits cancer cell proliferation. These results indicate that PRMT5 overexpression epigenetically alters the transcription of key tumor suppressor genes and suggest a causal role of the elevated symmetric methylation of H3R8 and H4R3 at the RBL2 promoter in transformed B-lymphocyte pathology.Keywords
This publication has 45 references indexed in Scilit:
- Increased Expression of the Polycomb Group Gene, EZH2, in Transitional Cell Carcinoma of the BladderClinical Cancer Research, 2005
- B Cell Chronic Lymphocytic Leukemia: Lessons Learned from Studies of the B Cell Antigen ReceptorAnnual Review of Immunology, 2003
- The retinoblastoma tumour suppressor in development and cancerNature Reviews Cancer, 2002
- The polycomb group protein EZH2 is involved in progression of prostate cancerNature, 2002
- Rb targets histone H3 methylation and HP1 to promotersNature, 2001
- Methylation of histone H4 at arginine 3 occurs in vivo and is mediated by the nuclear receptor coactivator PRMT1Current Biology, 2001
- The Polycomb group protein EZH2 is upregulated in proliferating, cultured human mantle cell lymphomaBritish Journal of Haematology, 2001
- The Rb/E2F pathway: expanding roles and emerging paradigmsGenes & Development, 2000
- DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promotersNature Genetics, 2000
- Exit from G1 and S Phase of the Cell Cycle Is Regulated by Repressor Complexes Containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNFCell, 2000